Oral dosing of Recombinant Methioninase Is Associated With...

Anticancer research 2020 / 05 Vol. 40; Iss. 5

Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient

HAN, QINGHONG, TAN, YUYING, HOFFMAN, ROBERT M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
40
Journal:
Anticancer Research
DOI:
10.21873/anticanres.14254
Date:
May, 2020
File:
PDF, 196 KB
2020
Conversion to is in progress
Conversion to is failed